Immunophenotyping based Cell Status Characterization Services
Background Service Highlights FAQs Contact Us
The Nexus of Immunophenotyping and Cell Status Characterization
Cell status characterization broadly encompasses the thorough analysis of cellular properties—including identity, purity, and functionality—to gain a comprehensive understanding of a cell's current biological state and behavior. Within this expansive field, immunophenotyping emerges as a critical technique, specifically leveraging the detection of unique cellular markers, or antigens, predominantly on white blood cells (WBCs), including T cells. These antigens serve as molecular barcodes, indicating specific cell types, maturation stages, and functional states.
The dynamic interplay between cellular activation, differentiation, and exhaustion is fundamental to immune responses in health and disease. For instance, activated cells often upregulate markers such as CD38+HLA-DR+, signaling their engagement in an immune process. T cells, a primary focus of many immunological studies, undergo distinct differentiation pathways, transitioning from naive states (e.g., CCR7+CD45RA+CD28+CD27+) to various memory subsets (Central Memory, Effector Memory) and terminally differentiated effector cells. Each stage is defined by a unique constellation of surface and intracellular markers. Furthermore, in contexts like chronic infections or cancer, T cells can enter a state of "exhaustion," characterized by a diminished capacity to secrete effector cytokines and the co-expression of multiple inhibitory receptors (IRs), such as PD-1, TIM-3, LAG-3, TIGIT, and CTLA-4. Creative Biolabs' expertise allows for the meticulous identification of these nuanced states, providing actionable data for our partners.
Fig.1 General scheme for immunophenotyping process by flow cytometry.1
Our Comprehensive Service Content: Unveiling Cellular Complexity
Creative Biolabs provides a robust suite of immunophenotyping-based cell status characterization services, meticulously designed to offer a multifaceted view of cellular behavior. Our integrated approach combines state-of-the-art technologies, ensuring accurate, high-resolution data that addresses the most challenging research questions.
Understanding the activation status of immune cells is critical for deciphering the progression of immune responses, both beneficial and detrimental. Creative Biolabs offers comprehensive services to characterize cell activation, primarily through the precise detection of specific activation markers. For instance, activated T cells are often identified by the upregulation of surface markers like CD38 and HLA-DR (CD38+HLA-DR+). Our flow cytometry panels are custom-designed to detect these and other relevant activation markers, providing quantitative data on the proportion and intensity of activated cell populations. This service is invaluable for researchers investigating immune responses in various contexts, including infectious diseases, autoimmune disorders, and cancer, allowing for a clear understanding of immune cell engagement and responsiveness. Creative Biolabs ensures accurate assessment of cellular activation to support your research objectives.
Immune cells, particularly T cells, undergo complex differentiation pathways to acquire specialized functions. Characterizing these differentiation stages is essential for understanding immune memory, protective immunity, and disease pathogenesis. Creative Biolabs provides detailed immunophenotyping services to delineate the differentiation status of various immune cell subsets. Such as for T cells, this includes identifying:
-
Naive T cells: Typically characterized by markers such as CCR7+CD45RA+CD28+CD27+.
-
Central Memory (CM) T cells: Identified by CCR7−CD45RA+CD28+CD27+/−.
-
Effector Memory (EM) T cells: Defined by CCR7−CD45RA−CD28+/−CD27+/−.
-
Terminal Effector (TE) T cells: Characterized by CCR7−CD45RA+CD28−CD27+/−.
-
Memory precursor cells: Identified through TCF1 expression.
Our advanced flow cytometry capabilities allow for the simultaneous detection of multiple differentiation markers, enabling the precise phenotyping and quantification of these distinct populations. This service is crucial for studies focusing on vaccine development, chronic diseases, and adoptive cell therapies, providing a roadmap of immune cell maturation and specialization.
T cell exhaustion is a state of T cell dysfunction that arises during chronic antigen exposure, such as in persistent viral infections and cancer. Exhausted T cells exhibit reduced effector functions, including impaired cytokine secretion, and critically, co-express multiple inhibitory receptors (IRs). Creative Biolabs specializes in identifying and quantifying exhausted T cell populations. Our panels include key inhibitory receptors such as PD-1, TIM-3, LAG-3, TIGIT, and CTLA-4. While individual expression of an IR may not always indicate exhaustion, the co-expression of multiple IRs is considered a hallmark of this state. Additionally, markers like PD1+CD57+ are often used to identify exhausted or senescent cells. By meticulously assessing the expression patterns of these markers using advanced flow cytometry and complementary single-cell RNA sequencing, Creative Biolabs provides critical insights into the dysfunctional state of T cells. This service is indispensable for immunooncology research and the development of immune checkpoint blockade therapies aimed at reversing T cell exhaustion and restoring anti-tumor immunity.
Our Advantages
With over 20 years dedicated to advancing biological understanding, Creative Biolabs offers an unparalleled advantage in immunophenotyping-based cell status characterization. Our strength lies in:
-
Integrated Platform Expertise
-
Scientific Rigor and Precision
-
Diverse Sample Versatility
-
Actionable Insights
FAQs
Q1: What types of cells can Creative Biolabs characterize using immunophenotyping?
A1: Creative Biolabs specializes in the characterization of immune cells, including various subsets of T cells (e.g., CD4+, CD8+, Naive, Memory, Effector), B cells, NK cells, and myeloid cells. Our capabilities also extend to identifying and characterizing specific cell types within complex heterogeneous samples such as tumor tissues.
Q2: What are the typical sample requirements for these services?
A2: Sample requirements vary based on the specific service and organism. We commonly work with peripheral blood, bone marrow, fresh or frozen tissue biopsies (especially tumors), dissociated cells, and cell lines. Our team provides detailed sample preparation guidelines to ensure optimal results.
Q3: How does Creative Biolabs ensure data quality and reproducibility?
A3: Creative Biolabs employs rigorous quality control measures at every step of the process, from sample receipt and processing to data acquisition and analysis. Our experienced scientists follow validated protocols, utilize calibrated instruments, and apply advanced bioinformatics tools to ensure data integrity, accuracy, and reproducibility across all experiments.
Contact Us
In the rapidly evolving landscape of biological research, precise cell status characterization is non-negotiable. Creative Biolabs stands as your trusted partner, offering unparalleled expertise and a comprehensive suite of immunophenotyping-based services. By leveraging our two decades of experience and state-of-the-art technologies, we empower researchers to gain profound insights into cellular behavior, accelerating discovery and innovation. Contact Creative Biolabs today to discuss how our advanced services can support your next groundbreaking project.
Reference
-
Johnson, Victor J et al. "Application and interpretation of immunophenotyping data in safety and risk assessment." Frontiers in toxicology vol. 6 1409365. 4 Oct. 2024. DOI: 10.3389/ftox.2024.1409365. Distributed under Open Access License CC BY 4.0, without modification.
